ERINN BASISTA: Open Payments
NPI 1457954471 · RUSSELLVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 18 payments from 13 companies in 2025. Trend: 2023 $979 · 2024 $966 · 2025 $861
Food & beverage: $861
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $163 |
| AstraZeneca Pharmaceuticals LP | 2 | $137 |
| Axsome Therapeutics, Inc. | 2 | $131 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $129 |
| Kestra Medical Technology Services, Inc. | 1 | $88 |
| Phathom Pharmaceuticals, Inc. | 1 | $63 |
| ABBVIE INC. | 2 | $36 |
| Dexcom, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
Products named: Ozempic, Auvelity, Kerendia, BREZTRI, Assure WCD, VOQUEZNA, VRAYLAR, Dexcom G6 Transmitter.
Industry payments across KY — which companies pay providers there.
